A fibrinolytic and thrombolytic enzyme from Aspergillus oryzae. EC 3.4.99.-.
Enzymes that catalyze reversibly the formation of an epoxide or arene oxide from a glycol or aromatic diol, respectively.
Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases (GLYCOSIDE HYDROLASES), lipases, NUCLEOTIDASES, peptidases (PEPTIDE HYDROLASES), and phosphatases (PHOSPHORIC MONOESTER HYDROLASES). EC 3.
The multifunctional protein that contains two enzyme domains. The first domain (EC 3.2.1.62) hydrolyzes glycosyl-N-acylsphingosine to a sugar and N-acylsphingosine. The second domain (EC 3.2.1.108) hydrolyzes LACTOSE and is found in the intestinal brush border membrane. Loss of activity for this enzyme in humans results in LACTOSE INTOLERANCE.
A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.
The facilitation of biochemical reactions with the aid of naturally occurring catalysts such as ENZYMES.
The rate dynamics in chemical or physical systems.
Endopeptidases that are specific for AMYLOID PROTEIN PRECURSOR. Three secretase subtypes referred to as alpha, beta, and gamma have been identified based upon the region of amyloid protein precursor they cleave.
Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.
The highest dose of a biologically active agent given during a chronic study that will not reduce longevity from effects other than carcinogenicity. (from Lewis Dictionary of Toxicology, 1st ed)
A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES.

The enhancing influence of proteolysis on E rosette forming lymphocytes (T cells) in vivo and in vitro. (1/1)

The T lymphocytes populations of 22 young healthy adults, 21 healthy middle aged and older blood donors, 35 non-pregnant women of child bearing age and 14 patients with advanced malignant disease were assessed and compared. It was found that the mean T cell counts in the middle aged and older controls were significantly lower than in the healthy young adults and were further reduced in the patients with malignant disease. The addition of the proteolytic agent brinase (protease 1 obtained from Aspergillus oryzae) to the rosetting test increased the T cell counts signficantly in all groups. This was mot marked in the older age groups and the patients with malignant disease. The proteolytic agent is shown to exert its effect on the lymphocytes in the test. Slow intravenous infusion of either brinase or streptokinase into patients with malignant disease is shown to result in increased T lymphocyte counts pari passu with a restoration of skin allergy. The significance of these findings and possible mode of action of the proteolytic agents in increasing T cell activity are discussed.  (+info)

The Burmese Tobacco Trading Company plans to roll out the Don Alejo Robaina Cigar brand in 2018, with plans to distribute in Europe, North America, and Asian markets. The Don Alejo Robaina brand will be dedicated to the memory of the Godfather of Cuban ...
The brain is an amazing organ! From your five senses to dreaming and memories, your brain is involved in almost everything you do. Fire up your synapses and learn about the cutting-edge field of neuroscience through hands-on experiments and innovative lab activities.Three Thursdays, 4:30 - 6:00 PM: November 7, 14 and 21, 2013ORThree Wednesdays, 4:30 - 6:00 PM: January 8, 15 and 22, 2014
... (or brinolase) is a fibrinolytic enzyme, and a thrombolytic drug. It is derived from Aspergillus oryzae. Aspergillus ... Brinolase at the US National Library of Medicine Medical Subject Headings (MeSH) v t e. ...
... brinolase MeSH D08.811.277.656.300.133 - cathepsins MeSH D08.811.277.656.300.133.062 - carboxypeptidase c MeSH D08.811.277.656. ...
"Brinolase" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... This graph shows the total number of publications written about "Brinolase" by people in this website by year, and whether " ... Below are the most recent publications written about "Brinolase" by people in Profiles. ...
Brinase (or brinolase) is a fibrinolytic enzyme, and a thrombolytic drug. It is derived from Aspergillus oryzae. Aspergillus ... Brinolase at the US National Library of Medicine Medical Subject Headings (MeSH) v t e. ...
... brinolase MeSH D08.811.277.656.300.133 - cathepsins MeSH D08.811.277.656.300.133.062 - carboxypeptidase c MeSH D08.811.277.656. ...
Brinolase - Preferred Concept UI. M0002923. Scope note. A fibrinolytic and thrombolytic enzyme from Aspergillus oryzae. EC 3.4. ...
Brinolase *Coagulase *Metalloendopeptidases � + *Serine Endopeptidases � + *Streptokinase � + *Exopeptidases *Aminopeptidases ...
Brinolase *Coagulase *Metalloendopeptidases + *Serine Endopeptidases + *Streptokinase + *Exopeptidases *Aminopeptidases + * ...
The effects of brinolase (fibrinolytic enzyme from Aspergillus Oryzae) on platelet aggregation of dog and man. ...
Tsai CH, Teng CH, Tu YT, Cheng TS, Wu SR, Ko CJ, Shyu HY, Lan SW, Huang HP, Tzeng SF, Johnson MD, Lin CY, Hsiao PW, Lee MS. HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase. Oncogene. 2014 Sep 18; 33(38):4643-52 ...
This graph shows the total number of publications written about "ATP-Dependent Endopeptidases" by people in this website by year, and whether "ATP-Dependent Endopeptidases" was a major or minor topic of these publications ...
... brinolase, Hageman factor (i.e. factor XII) fragments, plasminogen activators such as, for example, streptokinase, tissue ...
Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen ...
Brinolase. *Brinsley Animal Rescue. *Brinsmead Ziola Kennedy Architecture. *Brinson Partners Global Security Market Index ...
Gao G, Plaas A, Thompson VP, Jin S, Zuo F, Sandy JD. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J Biol Chem. 2004 Mar 12; 279(11):10042-51 ...
Hoffman LM, Fouladi M, Olson J, Daryani VM, Stewart CF, Wetmore C, Kocak M, Onar-Thomas A, Wagner L, Gururangan S, Packer RJ, Blaney SM, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ. Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study. Childs Nerv Syst. 2015 Aug; 31(8):1283-9 ...
Wang S, Kollipara RK, Srivastava N, Li R, Ravindranathan P, Hernandez E, Freeman E, Humphries CG, Kapur P, Lotan Y, Fazli L, Gleave ME, Plymate SR, Raj GV, Hsieh JT, Kittler R. Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. Proc Natl Acad Sci U S A. 2014 Mar 18; 111(11):4251-6 ...
Brinolase , Catheterization, Central Venous , Renal Dialysis , Thrombosis 7. Ruptura carotídea durante angioplastia: tratamento ...
D08.811.277.656.300.099 Brinolase .. D12 Amino cidos, Pept deos e Prote nas .. D12.644 Pept deos .. D12.644.360 Pept deos e ...
  • Brinase (or brinolase) is a fibrinolytic enzyme, and a thrombolytic drug. (wikipedia.org)